menu

MENU

繁體中文

Contact Us

Menu

Menu

Company

Introduction
Team & Board of Directors
Partners
Investors
Latest News

R&D Pipeline

Overview
Intranasal Vaccines
Asthma Immunotherapy
Respiratory Antiviral Immunotherapy

Company

Introduction

Team & Board of Director

Partners

Investors

Latest News

R&D Pipeline

Overview

Intranasal Vaccines

Asthma Immunotherapy

Respiratory Antiviral Immunotherapy

Contact us

Latest News

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form

April 16, 2023

本公司COVID-19治療 IIA期人體臨床試驗最後一位受試者完成投藥

Updates

April 16, 2023

【經濟日報】昱厚鼻噴氣喘新藥 獲准進行台灣學術用二期臨床試驗

Press

February 21, 2023

【環球生技月刊】次世代疫苗劑型受看好！ 鼻噴、微針貼片新冠疫苗 昱厚、怡定興全力研發中

Press

January 7, 2023

【環球生技月刊】《Cell》首證新冠病毒穿透鼻腔細胞機制！ 鼻噴藥物可望成解方

Press

November 28, 2022

【信傳媒】不只新藥獨占鰲頭 從試劑、疫苗到細胞治療 精準健康成生技業新趨勢

Press